Anavex

+$0.61 (+5.28%) Today
+$0.18 (+1.48%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.

CEO
Christopher U. Missling
Employees
25
Headquarters
New York, New York
Founded
2004

AVXL Key Statistics

Market cap
925.14M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.18M
High today
$12.17
Low today
$11.34
Open price
$11.55
Volume
795.58K
52 Week high
$31.50
52 Week low
$6.12

AVXL Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected Feb 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure